Targeted drug delivery: Binding and uptake of plant lectins using human 5637 bladder cancer cells

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 70, Issue 2, 2008, Pages 572-576

  Plattner, Verena E ^a   Wagner, Maria ^a   Ratzinger, Gerda ^a   Gabor, Franz ^a   Wirth, Michael ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

5637 cells; Bioadhesion; Bladder; Drug targeting; Lectins

Indexed keywords

ALPHA LEVO FUCOSE; FUCOSE; MONENSIN; N ACETYLGLUCOSAMINE; PLANT LECTIN; SIALIC ACID; ULEX EUROPAEUS AGGLUTININ; UNCLASSIFIED DRUG; WHEAT GERM AGGLUTININ;

ACIDITY; ARTICLE; BLADDER CANCER; CANCER CELL CULTURE; CELLULAR DISTRIBUTION; CULTURE MEDIUM; CYTOPLASM; DRUG DELIVERY SYSTEM; DRUG TARGETING; FLOW CYTOMETRY; FLUORESCENCE; FLUOROMETRY; GLYCOCALYX; HUMAN; HUMAN CELL; INTERNALIZATION; MONOLAYER CULTURE;

CELL LINE, TUMOR; DRUG DELIVERY SYSTEMS; FLOW CYTOMETRY; FLUOROMETRY; HUMANS; PLANT LECTINS; URINARY BLADDER NEOPLASMS; WHEAT GERM AGGLUTININS;

EID: 52949084744     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2008.06.004     Document Type: Article

References (23)

1. Parkin D.M., Whelan S.L., Ferlay J., Teppo L., and Thomas D.B. Cancer incidence in five continents. IARC Sci. Publ. 155 (2002) 1-773
2. Clark P.E. Bladder cancer. Curr. Opin. Oncol. 19 (2007) 241-247
3. Grossman H.B. Contemporary diagnosis and management of urethelial carcinoma. Urology 67 (2006) 1-2
4. Dinney C.P.N. Therapy of invasive bladder cancer. Urology 67 (2006) 56-59
5. Raghavan D. Molecular targeting and pharmacogenomics in the management of advanced bladder cancer. Cancer 97 (2003) 2083-2089
6. Grossman H.B., Natale R.B., Tangen C.M., Speights V.O., Vogelzang N.J., and L Trump D. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N. Engl. J. Med. 349 (2003) 859-866
7. Kolaczyk W., Dembowski J., Lorenz J., and Dudek J. Evaluation of the influence of systemic neoadjuvant chemotherapy on the survival of patients treated for invasive bladder cancer. BJU Int. 89 (2002) 616-619
8. Derycke A.S., Kamuhabwa A., Gijsens A., Roskams T., De Vos D., Kasran A., Huwyler J., Missiaen L., and de Witte P.A. Transferrin-conjugated liposome targeting of photosensitizer AlPcS4 to rat bladder carcinoma cells. J. Natl. Cancer Inst. 96 (2004) 1620-1630
9. Low P.S., and Antony A.C. Folate receptor-targeted drugs for cancer and inflammatory diseases. Adv. Drug Deliv. Rev. 56 (2004) 1055-1058
10. Gabor F., and Wirth M. Lectin-mediated drug delivery: fundamentals and perspectives. STP Pharm. Sci. 13 (2003) 3-16
11. Sharon N., and Lis H. Lectins: cell agglutination and sugar specific proteins. Science 177 (1972) 949-959
12. Singhal A., and Hakomori S. Molecular changes in carbohydrate antigens associated with cancer. Bioessays 12 (1990) 223-230
13. Gabor F., Stangl M., and Wirth M. Lectin-mediated bioadhesion: binding characteristics of plant lectins on the enterocyte-like cell lines Caco-2, HT-29, HCT-8. J. Control Release 55 (1998) 131-142
14. Gabor F., Klausegger U., and Wirth M. The interaction between wheat germ agglutinin and other plant lectins with prostate cancer cells Du-145. Int. J. Pharm. 221 (2001) 35-47
15. Montironi R., and Lopez-Beltran A. The 2004 WHO classification of bladder tumors: a summary and commentary. Int. J. Surg. Pathol. 13 (2005) 143-153
16. Wirth M., Kneuer C., Lehr C.M., and Gabor F. Studying cellular binding and uptake of bioadhesive lectins. In: Lehr C.M. (Ed). Cell Culture Models of Biological Barriers (2002), Taylor and Francis, London 62-93
17. van der Poel H.G., Molenaar B., van Beusechem V.W., Haisma H.J., Rodriquez R., Curiel D.T., and Gerritsen W.R. Epidermal growth factor receptor targeting of replication competent adenovirus enhances cytotoxicity in bladder cancer. J. Urol. 168 (2002) 266-272
18. Vale R.D., and Shooter E.M. Epidermal growth factor on PC12 cells: alteration of binding properties by lectins. J. Cell Biochem. 22 (1983) 99-109
19. Lochner N., Pittner F., Wirth M., and Gabor F. Wheat germ agglutinin binds to the epidermal growth factor receptor of artificial Caco-2 membranes as detected by silver nanoparticle enhanced fluorescence. Pharm. Res. 20 (2003) 833-839
20. Kuncova J., Kostrouch Z., Viale M., Revoltella R., and Mandys V. Expression of CD44v6 correlates with cell proliferation and cellular atypia in urothelial carcinoma cell lines 5637 and HT1197. Folia Biol. (Praha) 51 (2005) 3-11
21. Gabor F., Bogner E., Weissenboeck A., and Wirth M. The lectin-cell interaction and its implications to intestinal lectin-mediated drug delivery. Adv. Drug Deliv. Rev. 56 (2004) 459-480
22. Recker F., Otto T., and Rubben H. Lectins in diagnosis of bladder carcinoma. Urol. Int. 48 (1992) 149-153
23. Dmitruk I.M., Zerbino D.D., and Lutsik A.D. Lectin receptors in transitional cell tumors of the bladder. Vopr. Onkol. 33 (1987) 60-65